Syndax Pharmaceuticals Inc - Common Stock (SNDX)

CUSIP: 87164F105

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / Common Stock
Shares outstanding
86,727,396
Total 13F shares
34,234,622
Share change
+1,597,106
Total reported value
$505,296,990
Put/Call ratio
95%
Price per share
$14.76
Number of holders
98
Value change
+$23,535,263
Number of buys
43
Number of sells
47

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 87164F105?
CUSIP 87164F105 identifies SNDX - Syndax Pharmaceuticals Inc - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of SNDX - Syndax Pharmaceuticals Inc - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
4.3%
3,756,748
$55,676,000 30 Jun 2020
13F
BVF INC/IL
13F
Company
2.8%
2,470,678
$36,615,000 30 Jun 2020
13F
Boxer Capital, LLC
13F
Company
2.6%
2,287,782
$33,905,000 30 Jun 2020
13F
MPM ASSET MANAGEMENT LLC
13F
Company
2.5%
2,168,691
$32,140,000 30 Jun 2020
13F
BlackRock Finance, Inc.
13F
Company
2.5%
2,142,069
$31,747,000 30 Jun 2020
13F
Avidity Partners Management LP
13F
Company
1.8%
1,527,400
$22,636,000 30 Jun 2020
13F
VANGUARD GROUP INC
13F
Company
1.7%
1,432,540
$21,230,000 30 Jun 2020
13F
FRAZIER MANAGEMENT LLC
13F
Company
1.5%
1,320,045
$19,563,000 30 Jun 2020
13F
ORBIMED ADVISORS LLC
13F
Company
1.3%
1,094,100
$16,215,000 30 Jun 2020
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
1.2%
1,050,000
$15,561,000 30 Jun 2020
13F
CITADEL ADVISORS LLC
13F
Company
1.2%
1,041,580
$15,436,000 30 Jun 2020
13F
Aisling Capital Management LP
13F
Company
1.2%
1,025,000
$15,191,000 30 Jun 2020
13F
RA CAPITAL MANAGEMENT, L.P.
13F
Company
1.2%
1,023,067
$15,162,000 30 Jun 2020
13F
683 Capital Management, LLC
13F
Company
1.2%
1,016,371
$15,062,000 30 Jun 2020
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
1%
883,236
$13,089,000 30 Jun 2020
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.99%
862,048
$12,776,000 30 Jun 2020
13F
VR Adviser, LLC
13F
Company
0.72%
625,710
$9,273,000 30 Jun 2020
13F
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
0.57%
492,500
$7,299,000 30 Jun 2020
13F
STATE STREET CORP
13F
Company
0.55%
473,120
$7,012,000 30 Jun 2020
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.5%
437,462
$6,483,000 30 Jun 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.48%
414,690
$6,145,000 30 Jun 2020
13F
DAFNA Capital Management LLC
13F
Company
0.42%
360,000
$5,335,000 30 Jun 2020
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.41%
354,811
$5,258,000 30 Jun 2020
13F
NORTHERN TRUST CORP
13F
Company
0.41%
354,749
$5,257,000 30 Jun 2020
13F
S.c.a. Candriam
13F
Individual
0.4%
347,458
$5,150,000 30 Jun 2020
13F
ACUTA CAPITAL PARTNERS, LLC
13F
Company
0.28%
240,744
$3,568,000 30 Jun 2020
13F
Hudson Bay Capital Management LP
13F
Company
0.25%
220,300
$3,264,000 30 Jun 2020
13F
SPHERA FUNDS MANAGEMENT LTD.
13F
Company
0.25%
220,000
$3,260,000 30 Jun 2020
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.23%
200,552
$2,972,000 30 Jun 2020
13F
Ghost Tree Capital, LLC
13F
Company
0.21%
185,000
$2,742,000 30 Jun 2020
13F
MACQUARIE GROUP LTD
13F
Company
0.21%
180,000
$2,668,000 30 Jun 2020
13F
Assenagon Asset Management S.A.
13F
Company
0.21%
178,192
$2,641,000 30 Jun 2020
13F
MORGAN STANLEY
13F
Company
0.17%
150,065
$2,223,000 30 Jun 2020
13F
Palo Alto Investors LP
13F
Company
0.15%
127,700
$1,893,000 30 Jun 2020
13F
Nuveen Asset Management, LLC
13F
Company
0.14%
117,303
$1,739,000 30 Jun 2020
13F
Russell Investments Group, Ltd.
13F
Company
0.12%
104,122
$1,541,000 30 Jun 2020
13F
Bank of New York Mellon Corp
13F
Company
0.12%
103,541
$1,534,000 30 Jun 2020
13F
D. E. Shaw & Co., Inc.
13F
Company
0.12%
100,591
$1,491,000 30 Jun 2020
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.11%
94,700
$1,403,000 30 Jun 2020
13F
Sofinnova Investments, Inc.
13F
Company
0.11%
91,964
$1,363,000 30 Jun 2020
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.1%
87,285
$1,292,000 30 Jun 2020
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.08%
69,475
$1,030,000 30 Jun 2020
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.08%
66,419
$985,000 30 Jun 2020
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.07%
59,591
$883,000 30 Jun 2020
13F
CREDIT SUISSE AG/
13F
Company
0.06%
51,934
$770,000 30 Jun 2020
13F
BARCLAYS PLC
13F
Company
0.06%
49,648
$736,000 30 Jun 2020
13F
LOS ANGELES CAPITAL MANAGEMENT LLC
13F
Company
0.06%
49,020
$726,000 30 Jun 2020
13F
SIMPLEX TRADING, LLC
13F
Company
0.05%
46,663
$691,000 30 Jun 2020
13F
CITIGROUP INC
13F
Company
0.05%
46,375
$687,000 30 Jun 2020
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.05%
45,822
$679,000 30 Jun 2020
13F

Institutional Holders of Syndax Pharmaceuticals Inc - Common Stock (SNDX) as of Q3 2020

As of 30 Sep 2020, Syndax Pharmaceuticals Inc - Common Stock (SNDX) was held by 98 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,234,622 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, BVF INC/IL, BOXER CAPITAL, LLC, BlackRock Inc., Avidity Partners Management LP, MPM ASSET MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, Nantahala Capital Management, LLC, and FRAZIER MANAGEMENT LLC. This page lists 98 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders
96
Q3 2020 holders
98
Holder diff
2
Investor Q2 2020 Shares Q3 2020 Shares Share Diff Share Chg % Q2 2020 Value $ Q3 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.